Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal composition for treating neuropathic pain

A composition and neurological technology, applied in drug combination, neurological diseases, pharmaceutical formulations, etc., can solve problems such as adverse reactions, achieve significant curative effect and enhance the effect of medicine

Inactive Publication Date: 2013-01-09
TAISHAN MEDICAL UNIV
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Anticonvulsants, opioids, and antidepressants are often used for treatment, but most products are not specific for neuropathic pain, and most of them are ineffective or only moderately relieve pain for most patients, and can cause adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Pharmaceutical composition for treating neuropathic pain

[0019] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of neuropathic pain are:

[0020] 1 part by weight of magnolialine, 5 parts by weight of ranunculin, 5 parts by weight of piperine, and 8 parts by weight of eugenol.

Embodiment 2

[0021] Embodiment 2: the pharmaceutical composition for the treatment of neuropathic pain

[0022] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of neuropathic pain are:

[0023] 10 parts by weight of magnolialine, 10 parts by weight of ranunculin, 1 part by weight of piperine, and 10 parts by weight of eugenol.

Embodiment 3

[0024] Embodiment 3: the pharmaceutical composition for the treatment of neuropathic pain

[0025] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of neuropathic pain are:

[0026] 4 parts by weight of magnolialine, 5 parts by weight of ranunculin, 10 parts by weight of piperine, and 1 part by weight of eugenol.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
decomposition temperatureaaaaaaaaaa
Login to View More

Abstract

The invention discloses a medicinal composition for treating neuropathic pain. The medicine provided by the invention is prepared by magnoflorine, ranunculin, piperine and eugenol as raw material medicines and can be prepared into various dosage forms according to a conventional preparation technology. With the adoption of the medicinal composition for treating neuropathic pain, the defects in the prior art can be overcome, and the invention provides the safe medicinal composition for treating neuropathic pain with significant efficacy. The medicine provided by the invention is simple in preparation method and low in cost, and clinical tests prove that the medicine for treating the neuropathic pain has significant clinical effects, including prosopalgia, ischialgia, radicular pain, postherpetic neuralgia and diabetic peripheral neuritis and the like.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating neuropathic pain. Background technique [0002] Neuropathic pain refers to pain syndromes caused by primary lesions or dysfunctions of the central or peripheral nervous system. It can be caused by trauma or / and disease-induced damage to peripheral nerves, posterior roots of the spinal cord, spinal cord and some parts of the central nervous system above. According to the etiology, nature and degree of nerve injury, it is clinically divided into two categories: central nerve pain and peripheral nerve pain caused by peripheral nerve injury. Central nerve pain, referred to as central pain, is primary pain caused by damage or dysfunction of the pain conduction pathway of the central nervous system. It is commonly seen in spinal cord trauma or cerebrovascular diseases, multiple sclerosis and tumors. Peripheral nerve pain is caused...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/473A61K31/4525A61K31/085A61P25/04A61P25/02
Inventor 孔倩倩
Owner TAISHAN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com